# US 2019/0314529 A1 · Dye enhanced visualization of cataract surgery

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0314529 A1
- Document ID: US20190314529A1
- Status: Published application
- Kind: A1
- Application number: 15/953,310
- Filed: 2018-04-13
- Published: 2019-10-17
- Earliest claimed: 2018-04-13
- Assignees: EOS Holdings, LLC
- Applicants: Eos Holdings, LLC
- Inventors: David MORDAUNT
- Web page: https://patentgrep.com/patent/US20190314529A1

## CPC

- A61K 49/006: {Biological staining of tissues in vivo, e.g. methylene blue or toluidine blue O administered in the buccal area to detect epithelial cancer cells, dyes used for delineating tissues during surgery}
- A61B 34/30: Surgical robots
- A61F 2/1662: {Instruments for inserting intraocular lenses into the eye}
- A61F 9/008: using laser
- A61K 9/0048: {Eye, e.g. artificial tears}
- A61K 9/08: Solutions {(composition of solutions A61K47/00)}
- A61K 49/0071: {solution, solute}
- A61B 2218/002: Irrigation
- A61B 2218/007: Aspiration
- A61F 2009/0087: {Lens}
- A61F 2009/00887: {Cataract}
- A61F 2009/00889: {Capsulotomy}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)

## Abstract

The invention relates generally to the use of dyes to enhance visualization of tissues and boundaries of openings in tissues during cataract surgery.

## Claims

### Claim 1

An ophthalmic solution for enhancing visualization during cataract surgery, comprising:
an isotonic and pH neutral aqueous solution of Trypan Blue at a concentration of 0.2% to 0.45% by weight.

### Claim 2 (depends on 1)

The ophthalmic solution of claim 1, wherein the concentration of Trypan Blue is 0.25% to 0.45% by weight.

### Claim 3 (depends on 1)

The ophthalmic solution of claim 1, wherein the concentration of Trypan Blue is 0.3% to 0.45% by weight.

### Claim 4 (depends on 1)

The ophthalmic solution of claim 1, comprising one or more other dyes that absorb in the red and orange region of the spectrum, wherein the total concentration of Trypan Blue and the one or more other dyes is 0.2% to 0.45% by weight.

### Claim 5

A method to enhance visualization of tissues and boundaries of openings in tissues in an eye during cataract surgery, the method comprising:
providing or obtaining an ophthalmic solution comprising an isotonic and pH neutral aqueous solution of Trypan Blue at a concentration of 0.2% to 0.45% by weight;
applying the ophthalmic solution to lens capsule tissue in the eye for a time period of less than or equal to one minute to stain the lens capsule tissue with Trypan Blue; and
rinsing the ophthalmic solution from the eye.

### Claim 6 (depends on 5)

The method of claim 5, wherein the concentration of Trypan Blue is 0.25% to 0.45% by weight.

### Claim 7 (depends on 5)

The method of claim 5, wherein the concentration of Trypan Blue is 0.3% to 0.45% by weight.

### Claim 8 (depends on 5)

The method of claim 5, wherein the ophthalmic solution is applied to the lens capsule for a time period of less than or equal to 10 seconds.

### Claim 9 (depends on 8)

The method of claim 8, wherein the stained lens capsule tissue transmits less than or equal to 50% of light reflected from the retina.

### Claim 10 (depends on 9)

The method of claim 9, wherein the eye comprises a translucent cataract.

### Claim 11 (depends on 5)

The method of claim 5, comprising:
distinguishing between the stained lens capsule tissue and another tissue based on the intensities of light reflected from the retina of the eye through the two tissues; or
distinguishing between the stained lens capsule tissue in the lens capsule and an opening in that tissue based on the intensities of light reflected from the retina of the eye through that tissue and through the opening in that tissue; or
distinguishing between the stained lens capsule tissue and another tissue based on the intensities of light reflected from the retina of the eye through the two tissues and distinguishing between the stained lens capsule tissue in the lens capsule and an opening in that tissue based on the intensities of light reflected from the retina of the eye through that tissue and through the opening in that tissue.

### Claim 12 (depends on 11)

The method of claim 11, wherein the distinguishing is done visually by a human observer viewing the lens capsule.

### Claim 13 (depends on 11)

The method of claim 11, wherein the distinguishing comprises use of a machine vision system that images the lens capsule, determines intensity variations in the image, and utilizes anatomical recognition algorithms to determine the location in the image of a capsulotomy boundary in the lens capsule.

### Claim 14 (depends on 13)

The method of claim 13, wherein the anterior lens capsule location is identified, and this information used to guide robotic surgery to perform at least one of the following functions: placement and movement of a phacoemulsification hand piece to remove the natural crystalline lens, placement and movement of an irrigation and/or aspiration cannula to remove lens cortical, placement and movement of an irrigation and/or aspiration cannula to remove lens epithelial cells, operation of a laser system for the formation of a posterior capsulotomy, and guiding placement and movement of an artificial IOL during insertion and positioning in to the lens capsule.

### Claim 15 (depends on 11)

The method of claim 11, wherein lens epithelial cells are identified.

### Claim 16 (depends on 5)

The method of claim 5, comprising:
following capsulotomy and removal of the natural crystalline lens,
distinguishing between the lens capsule tissue stained by Trypan Blue and an opening in that tissue.

### Claim 17 (depends on 5)

The method of claim 5, comprising:
following capsulotomy and removal of the natural crystalline lens,
identifying lens epithelial cells stained by Trypan Blue.

### Claim 18 (depends on 5)

The method of claim 5, comprising:
following capsulotomy and removal of the natural crystalline lens,
distinguishing between anterior lens capsule tissue stained by Trypan Blue, posterior lens capsule stained by Trypan Blue, and openings in those tissues.
